4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-008063
Chief Medical Officer sold 100 shares at $25.00 ($2,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-01-26 | Sale 10b5-1 | −100 | $25.00 | $2,500 | 168,996 | D |
| Open-market sales · 100 sh · avg $25.00 · $2,500 | |||||||
Loading xslF345X05/ownership.xml…